China Universal Asset Management Co., Ltd. Cure Vac N.V. Transaction History
China Universal Asset Management Co., Ltd.
- $1.17 Billion
- Q3 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Cure Vac N.V. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 39,466 shares of CVAC stock, worth $208,380. This represents 0.02% of its overall portfolio holdings.
Number of Shares
39,466
Previous 45,222
12.73%
Holding current value
$208,380
Previous $245,000
13.47%
% of portfolio
0.02%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding CVAC
# of Institutions
106Shares Held
22.5MCall Options Held
124KPut Options Held
77.1K-
Glazer Capital, LLC New York, NY4.55MShares$24 Million0.82% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ2.3MShares$12.1 Million0.78% of portfolio
-
Black Rock Inc. New York, NY2.25MShares$11.9 Million0.0% of portfolio
-
Qube Research & Technologies LTD London, X01.71MShares$9.04 Million0.01% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$8.28 Million10.6% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $990M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...